What is the typical size of vessel anastomoses in twin anemia polycythemia syndrome (TAPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vessel Anastomoses Size in Twin Anemia-Polycythemia Sequence

The vessel anastomoses in TAPS are exclusively small-caliber arteriovenous connections measuring less than 1 millimeter in diameter, typically located near the placental edge. 1

Pathophysiologic Characteristics

The defining vascular feature of TAPS involves minuscule arteriovenous anastomoses (<1 mm) that facilitate slow, chronic blood transfusion between twins. 1, 2 These submillimeter connections are fundamentally different from the larger anastomoses seen in twin-twin transfusion syndrome (TTTS), which explains the distinct clinical presentation.

Blood Flow Dynamics

  • The rate of blood flow through these tiny anastomoses is approximately 5 to 15 mL per day, which is substantially slower than in TTTS 1
  • This slow transfusion rate allows for gradual hematologic compensation in earlier disease stages, explaining why amniotic fluid discordance is typically absent 1
  • The small caliber and low flow rate result in chronic anemia in the donor twin and polycythemia in the recipient twin without the oligohydramnios-polyhydramnios sequence characteristic of TTTS 3, 2

Diagnostic Confirmation

**Postnatal diagnosis of TAPS requires identification of exclusively small-vessel anastomoses (<1 mm) upon placental pathology examination**, along with either an intertwin hemoglobin difference of ≥8 g/dL or a reticulocyte ratio >1.7 between donor and recipient. 1

Key Diagnostic Points

  • The presence of only small-caliber anastomoses is pathognomonic for TAPS 2, 4
  • Larger anastomoses or arterio-arterial connections are typically absent in TAPS, distinguishing it from other forms of fetofetal transfusion 5, 2
  • These minuscule connections are commonly located near the placental edge rather than centrally 1

Clinical Implications

The submillimeter size of these anastomoses has important clinical ramifications:

  • Prevention strategy: The Solomon laser technique, which involves equatorial dichorionization, reduces post-laser TAPS from 15.6% to 2.9% by more completely addressing these tiny residual anastomoses 1, 5
  • Screening necessity: Because these anastomoses are too small to cause amniotic fluid abnormalities, TAPS requires specific MCA-PSV Doppler surveillance rather than relying on fluid discordance 1
  • Pathophysiology: The small caliber explains why TAPS can develop at any time from early second trimester through third trimester, as the slow transfusion process takes time to manifest clinically 6

Important Caveat

The presence of small-caliber arterio-arterial anastomoses in addition to the arteriovenous connections may provide some protective hemodynamic balance, though when present in TAPS cases, these AA anastomoses are also of low caliber 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Twin Anemia Polycythemia Sequence: Current Views on Pathogenesis, Diagnostic Criteria, Perinatal Management, and Outcome.

Twin research and human genetics : the official journal of the International Society for Twin Studies, 2016

Research

Spontaneous twin anemia-polycythemia sequence complicated by recipient placental vascular thrombosis and hydrops fetalis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.